Dual-Engineered Phage Vaccine Platform Facilitates STING Activation for Influenza Protection
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c16246 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Fei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, School of Rehabilitation Sciences and Engineering, University of Health and…. Hauptthemen laut MEDLINE: Influenza Vaccines, Oxides, Orthomyxoviridae Infections, Membrane Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Influenza epidemics remain a global public health challenge. Vaccination with nucleic acid-based vaccines, which trigger strong cellular and humoral immune responses, represents a promising approach for preventing virus infection. However, its effectiveness relies on efficient delivery and an immunoadjuvant. Here, we constructed a gene- and nanoengineered vaccine delivery platform via modifying MnO2 nanoparticles (NPs) onto the surface of the M13 phage, which carried the hemagglutinin stem gene of influenza A virus preceded by a eukaryotic initial transcriptional region. Specifically, the M13 phage protected the inserted nucleic acid vaccine against degradation due to the existence of capsid proteins. MnO2 NPs released Mn2+ ions under the acidic condition of endolysosomes, thereby promoting the cytoplasmic delivery of phage vaccines, which significantly improved the antigen expression. Moreover, Mn2+ acted as a potent adjuvant for dendritic cell maturation by activating the cGAS/STING pathway. Immunization with the engineered phage vaccine induced CD4+ T cell, CD8+ T cell, and humoral immune responses in mice. In infected mouse models, the vaccines ameliorated weight loss, survival rate, lung virus titers, and pulmonary pathologies and conferred full protection against influenza viruses. Collectively, we developed a dual-engineered phage vaccine platform, offering an alternative regimen for optimizing nucleic acid vaccines, which may have broad applications in the rational design of vaccine formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266024, China.
- Department of Cardiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362400, China.
- Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
- Department of Orthopedics, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225009, China.
ORCID-Profile: Gang Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Innovation of Science and Technology, Fujian Province
Zitieren
APA
Wang, F., Chen, S., Xia, Y., Liu, C., Xu, Z., Song, R., Liu, W., Liu, T., Chen, G., & Liu, Q. (2025). Dual-Engineered Phage Vaccine Platform Facilitates STING Activation for Influenza Protection. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c16246
Vancouver
Wang F, Chen S, Xia Y, Liu C, Xu Z, Song R, et al. Dual-Engineered Phage Vaccine Platform Facilitates STING Activation for Influenza Protection. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c16246
BibTeX
@article{Wang2025,
author = {Wang, Fei and Chen, Shuhan and Xia, Yinhe and Liu, Caihong and Xu, Zhou and Song, Ruilong and Liu, Wenfeng and Liu, Tingting and Chen, Gang and Liu, Qingquan},
title = {Dual-Engineered Phage Vaccine Platform Facilitates STING Activation for Influenza Protection},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c16246}
}
EUVIMED